Tom was on the National Pharmaceutical Congress podcast last week, talking about the importance of context and #Provenance, and of keeping humans in the driver's seat when using AI to support pharmaceutical research.
Grats to #BreadcrumbAnalytics on their work supporting a recent landmark study by #UBuffalo's Andy Talal on the efficacy of telemedicine in hepatitis-C treatment.
Quoth Tom:
> "By addressing the complex challenges of data reproducibility and governance, we ensure that critical research like this can lead to tangible improvements in patient care and treatment strategies."
Study Overview: https://medicine.buffalo.edu/news_and_events/news/2024/04/jama-talal-hcv-telemedicine-19662.html
Breadcrumb's Post: https://www.linkedin.com/posts/breadcrumb-analytics_ai-datascience-healthcareinnovation-activity-7264989620046577665-kZ1I
People with opioid use disorder who have hepatitis C virus were twice as likely to be successfully treated and cured if they received facilitated telemedicine treatment at their opioid treatment program.
Alright... I've been putting this nonsense off for long enough. With much fanfare 🎉, the massive frontend rework that started on Amtrak's Empire Builder back in Summer '21, is now ready for public consumption.
Our workflow-style notebook #Vizier is officially 2.0 🎂.
Get it while it's hot: https://github.com/VizierDB/vizier-scala/releases/tag/v2.0.1
Feedback welcome: https://github.com/VizierDB/vizier-scala/issues